Visby Medical Overview
- Founded
-
2012
- Status
-
Private
- Employees
-
249
- Latest Deal Type
-
Series E
- Latest Deal Amount
-
$144M
- Investors
-
30
Visby Medical General Information
Description
Developer of testing devices designed to diagnose coronavirus disease, Chlamydia, Gonorrhea, and Trichomonas. The company specializes in the development of single-use handheld over-the-counter testing kits that provide instrument-free results, enabling patients to get their conditions diagnosed easily and efficiently.
Contact Information
Website
www.visbymedical.com
Formerly Known As
Click Diagnostics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
- 3010 North First Street
- San Jose, CA 95134
- United States
+1 (833) 000-0000
Visby Medical Timeline
Visby Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series E) | 29-Jun-2022 | $144M | 00000 | Completed | Generating Revenue | |
| 9. Grant | 25-Mar-2022 | 000.00 | 00000 | Completed | Generating Revenue | |
| 8. Grant | 05-Aug-2020 | 0000 | 00000 | Completed | Generating Revenue | |
| 7. Later Stage VC (Series D) | 31-May-2020 | 00000 | 00000 | 00000 | Completed | Generating Revenue |
| 6. Later Stage VC (Series C) | 26-Jul-2019 | 00000 | 00000 | 00000 | Completed | Generating Revenue |
| 5. Grant | 01-Jan-2019 | 00000 | 0000 | Completed | Generating Revenue | |
| 4. Seed Round | 26-Jan-2018 | 0000 | Completed | Generating Revenue | ||
| 3. Grant | 01-Jan-2017 | 00.000 | 0000 | Completed | Generating Revenue | |
| 2. Early Stage VC (Series B) | 04-Nov-2015 | $16M | $22M | 0000 | Completed | Generating Revenue |
| 1. Early Stage VC (Series A) | 03-Jul-2013 | $6M | $6M | 000.00 | Completed | Generating Revenue |
Visby Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | 0,000,000 | 00.000000 | 00.00 | 000.00 | 000.00 | 00 | 000.00 | 0.00 |
| Series D | 0,000,000 | 00.000000 | 00.00 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
| Series C | 0,000,000 | 00.000000 | 00.00 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
| Series B | 4,571,428 | $0.000100 | $0.28 | $3.5 | $3.5 | 1x | $3.5 | 13.3% |
| Series A | 5,017,577 | $0.000100 | $0.1 | $1.2 | $1.2 | 1x | $1.2 | 14.59% |
Visby Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Visby Medical Patents
Visby Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4085149-A1 | Devices and methods for antibiotic susceptibility testing | Pending | 03-Jan-2020 | 000000000 | |
| US-20220372557-A1 | Devices and methods for antibiotic susceptability testing | Pending | 03-Jan-2020 | 000000000 | |
| US-11352675-B2 | Devices and methods for antibiotic susceptability testing | Active | 03-Jan-2020 | 000000000 | 000 |
| US-20210207194-A1 | Devices and methods for antibiotic susceptability testing | Active | 03-Jan-2020 | 000000000 | |
| EP-3962649-A4 | Molecular diagnostic devices with digital detection capability and wireless connectivity | Pending | 28-Apr-2019 | G16B20/00 | 0 |
Visby Medical Executive Team (10)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Adam de la Zerda Ph.D | Founder, Chief Executive Officer & Board Member | ||
| Mark Ibison | Chief Financial Officer | ||
| Don Yansen | Chief Operating Officer | ||
| Christopher Jowett | Chief Commercial Officer | ||
| David Shaw | Advisor |
Visby Medical Board Members (14)
| Name | Representing | Role | Since |
|---|---|---|---|
| Adam de la Zerda Ph.D | Visby Medical | Founder, Chief Executive Officer & Board Member | 000 0000 |
| Amit Shah | Artiman Ventures | Board Member | 000 0000 |
| Eric Moessinger | ND Capital | Board Member | 000 0000 |
| Everett Cunningham | Self | Board Member | 000 0000 |
| Ittai Harel | Pitango Venture Capital | Board Observer | 000 0000 |
Visby Medical Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Visby Medical Investors (30)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| 1809 Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Blue Water Life Science Advisors | Corporation | Minority | 000 0000 | 000000 0 | |
| Dynamic Loop Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Healthcare of Ontario Pension Plan | Limited Partner | Minority | 000 0000 | 000000 0 | |
| Lightrock | Impact Investing | Minority | 000 0000 | 000000 0 |